DuPont Merck’s Cardiolite
Executive Summary
Technetium-based cardiac imaging agent is approved for added indication of use during cardiac stress tests to determine patients at high risk for heart attack by identifying areas of ischemia and coronary artery disease, DuPont Merck says Sept. 10. Introduced in 1991, Cardiolite also is indicated for identifying abnormal heart tissue in patients with suspected myocardial infarction and for the assessment of ventricular function.